Restore study: Effects of a 24-week natalizumab treatment interruption on immune parameters and multiple sclerosis magnetic resonance imaging disease activity

Category Primary study
ConferenceNeurology
Year 2012
This article has no abstract
Epistemonikos ID: 4d39f868bf756059541cfd8459e29bae883fe275
First added on: Apr 30, 2026